These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 37199682

  • 1. Recurrent PAK2 rearrangements in poroma with folliculo-sebaceous differentiation.
    Kervarrec T, Pissaloux D, Paindavoine S, Tirode F, Osio A, Mourah S, Jouenne F, Sohier P, Calonje E, Pekar A, Luna EVE, Goto K, Delalande F, Frouin E, Macagno N, Drouot F, Faisan M, Cribier B, Battistella M, de la Fouchardière A.
    Histopathology; 2023 Aug; 83(2):310-319. PubMed ID: 37199682
    [Abstract] [Full Text] [Related]

  • 2. Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases.
    Kervarrec T, Westphal D, Pissaloux D, Legrand M, Tirode F, Neuhart A, Drouot F, Becker JC, Macagno N, Seris A, Jouary T, Beltzung F, Jullie ML, Harms PW, Cribier B, Mourah S, Jouenne F, Fromont G, Louveau B, Mancini M, Kazakov DV, de la Fouchardière A, Battistella M.
    Histopathology; 2024 Oct; 85(4):566-578. PubMed ID: 38785043
    [Abstract] [Full Text] [Related]

  • 3. Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: An update.
    Kervarrec T, Pissaloux D, Tirode F, de la Fouchardière A, Sohier P, Frouin E, Hamard A, Houben R, Schrama D, Barlier A, Cribier B, Battistella M, Macagno N.
    Histopathology; 2024 Jan; 84(2):266-278. PubMed ID: 37609771
    [Abstract] [Full Text] [Related]

  • 4. Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.
    Sekine S, Kiyono T, Ryo E, Ogawa R, Wakai S, Ichikawa H, Suzuki K, Arai S, Tsuta K, Ishida M, Sasajima Y, Goshima N, Yamazaki N, Mori T.
    J Clin Invest; 2019 May 30; 129(9):3827-3832. PubMed ID: 31145701
    [Abstract] [Full Text] [Related]

  • 5. A case of YAP1 and NUTM1 rearranged porocarcinoma with corresponding immunohistochemical expression: Review of recent advances in poroma and porocarcinoma pathogenesis with potential diagnostic utility.
    Parra O, Kerr DA, Bridge JA, Loehrer AP, Linos K.
    J Cutan Pathol; 2021 Jan 30; 48(1):95-101. PubMed ID: 32757412
    [Abstract] [Full Text] [Related]

  • 6. Spindle cell porocarcinoma with a novel YAP1::MAML3 fusion.
    Li P, Busam KJ.
    J Cutan Pathol; 2024 Mar 30; 51(3):226-229. PubMed ID: 38088454
    [Abstract] [Full Text] [Related]

  • 7. Poroid adnexal skin tumors with YAP1 fusions exhibit similar histopathologic features: A series of six YAP1-rearranged adnexal skin tumors.
    Prieto-Granada C, Morlote D, Pavlidakey P, Rodriguez-Waitkus P, Ramirez C, Florento E, Swensen J, Gatalica Z, Stevens TM.
    J Cutan Pathol; 2021 Sep 30; 48(9):1139-1149. PubMed ID: 33704800
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Molecular analysis of NUT-positive poromas and porocarcinomas identifies novel break points of YAP1::NUTM1 fusions.
    Snow JT, Georgantzoglou N, Green DC, Parra O, LeBlanc RE, Yan S, Sriharan A, Momtahen S, Winnick KN, Dimonitsas E, Stavrianos S, Lakiotaki E, Korkolopoulou P, Revelos K, Guo R, Linos K.
    J Cutan Pathol; 2022 Oct 30; 49(10):850-858. PubMed ID: 35665951
    [Abstract] [Full Text] [Related]

  • 10. Poroma with sebaceous differentiation: report of three cases.
    Kurashige Y, Yamamoto T, Okubo Y, Tsuboi R.
    Australas J Dermatol; 2010 May 30; 51(2):131-4. PubMed ID: 20546221
    [Abstract] [Full Text] [Related]

  • 11. Cuticular Poroma: A Rare Poroma Variant Simulating a Malignant Neoplasm That Often Harbors YAP1::NUTM1 Fusions Similar to Their Conventional Counterparts.
    Kolm I, Konstantinova AM, Kutzner H, Barghorn A, Vanecek T, Mangana J, Kazakov DV.
    Am J Dermatopathol; 2023 Aug 01; 45(8):544-548. PubMed ID: 37335840
    [Abstract] [Full Text] [Related]

  • 12. [Apocrine poroma. A relatively little known skin tumor with multilineage differentiation].
    Flux K, Eckert F.
    Pathologe; 2014 Sep 01; 35(5):456-61. PubMed ID: 25142043
    [Abstract] [Full Text] [Related]

  • 13. NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid Neoplasms.
    Macagno N, Kervarrec T, Sohier P, Poirot B, Haffner A, Carlotti A, Balme B, Castillo C, Jullie ML, Osio A, Lehmann-Che J, Frouin E, Battistella M.
    Am J Surg Pathol; 2021 Sep 01; 45(9):1221-1227. PubMed ID: 33739783
    [Abstract] [Full Text] [Related]

  • 14. Holocrine Poroma: A Distinctive Adnexal Tumor.
    Horenstein MG, Sandoval MP, Lo Y, Jacob J.
    Am J Dermatopathol; 2018 Jun 01; 40(6):401-408. PubMed ID: 29095742
    [Abstract] [Full Text] [Related]

  • 15. YAP1::MAML2 fusions in poromatosis: A report of two patients.
    Mitsui Y, Ogawa K, Goto K, Fujii T, Nakamura-Nishimura Y, Mashiba K, Asada H.
    J Cutan Pathol; 2023 Aug 01; 50(8):695-701. PubMed ID: 36723803
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma.
    Russell-Goldman E, Hornick JL, Hanna J.
    J Cutan Pathol; 2021 Mar 01; 48(3):403-410. PubMed ID: 33222286
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sebocrine adenoma. An adnexal adenoma with sebaceous and apocrine poroma-like differentiation.
    Zaim MT.
    Am J Dermatopathol; 1988 Aug 01; 10(4):311-8. PubMed ID: 2843062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.